Intermittent fasting may reduce symptoms in Alzheimer’s disease
Alzheimer's disease is known to disrupt circadian rhythms, affecting sleep patterns and cognitive function.
About 80% of Alzheimer's patients experience circadian issues, leading to a...
How new drug Lecanemab can treat Alzheimer’s disease
In the quest to treat Alzheimer's, a complex and devastating disease, researchers have long struggled to find effective therapies. The recent FDA approval of...
Scientists find a promising marker to accurately predict Alzheimer’s disease risk
New findings by neuroscience researchers at Wayne State University support the potential of blood neurofilament light (NfL) as a useful biomarker for predicting the...
A new Alzheimer’s treatment shows promise, but comes with side effects
Alzheimer's disease is a condition that affects memory and thinking skills, and it's the most common reason older people experience a decline in these...
New Alzheimer’s drugs don’t deserve the hype – here’s why
A prominent childhood memory is of my grandparents living with and then dying from dementia.
As is universal with dementia, there was a double blow:...
New blood test can detect Alzheimer’s disease more accurately
Alzheimer's disease is a common form of dementia, affecting millions of people around the world. As we age, the risk of developing this brain...
Research shows new hope for Alzheimer’s and Down syndrome treatments
For decades, scientists have thought they understood one of the key processes that helps our brains learn and remember.
However recent groundbreaking research from the...
The “good gene” that could protect you from Alzheimer’s and Parkinson’s
Do you know that some people have a natural defense against Alzheimer's and Parkinson's, two of the most common brain diseases that affect older...
Education can delay cognitive decline, even amidst genetic risks for Alzheimer’s
A groundbreaking study from Mass General Brigham indicates that the risk of Alzheimer's disease, including its genetically-determined forms, is not solely dictated by genetics.
The...
MIT scientists develop promising new drug to combat Alzheimer’s disease
In a groundbreaking study, scientists at The Picower Institute for Learning and Memory at MIT have developed a molecule named "A11," which shows promise...